Cryptocurrency & Digital Assets

JeffSTAT pilot Mike Moore hits a rare 3,000-transport milestone, highlighting a career of dedication and the critical role of air medical teams.

Taiwanese tech integrator SINBON debuts at ACT Expo, bringing advanced liquid-cooled and NACS charging solutions to the booming US commercial EV sector.

The visual app giant's pivot to AI agents drove a 65% profit surge and captured high-value global markets, redefining its future and business model.

As online betting fuels a surge in addiction, a new luxury treatment program highlights a national health crisis and raises questions about access to care.

Tired of costly cruise Wi-Fi? OneRoam launches a new travel eSIM with exclusively unlimited data plans for seamless connectivity at sea and on land.

Soaring diesel prices are pushing Canada's truckers to the brink, threatening a fragile recovery and signaling higher costs for consumers on everything.

The luxury tea brand and Reese Witherspoon's lifestyle label collaborate on a new spring collection, blending Southern grace with global tea culture.

The direct-to-consumer brand hit a $100M run rate with natural supplements, attracting major investors. But do the scientific claims hold up?

The biotech firm's oversubscribed funding round will accelerate its universal flu shot and a diverse pipeline targeting cancer, malaria, and Alzheimer's.

Birchtech launches its SEA-IX™ resin line, aiming to disrupt a consolidated market and bolster supply chains for critical nuclear and water utilities.

Danish firm Evaxion, backed by the Gates Foundation, uses its AI platform to design a next-gen polio vaccine, aiming to end the disease for good.

HistoSonics begins a landmark trial for a non-invasive BPH therapy that uses focused ultrasound to mechanically destroy tissue without incisions or heat.

A new partnership between Takara Bio and Hamilton promises to revolutionize RNA-seq, making high-throughput genomic analysis faster and more reliable.

Tenpoint Therapeutics launches YUVEZZI, a once-daily drop for presbyopia, entering a fierce market with a novel two-in-one formula for aging eyes.

An amended deal with Tasly positions AP Biosciences to license its innovative bispecific cancer therapy to global pharma giants, targeting a lucrative market.

Dubai's AIR, owner of Al Fakher, is going public via a SPAC merger. Can it navigate a tricky market and health debates to find growth on Wall Street?

South Korean AI chip leader Rebellions raises $400M, launching full-stack AI systems to redefine efficient inference and spearhead a global expansion.

Backed by a Turkish mining giant, Capella Minerals starts crucial soil sampling in Finland's prolific gold belt, seeking the next major discovery.

Chef Gabriela Cámara and architect Frida Escobedo debut a sanctuary of Mexican hospitality, offering a quiet, authentic counterpoint to the Vegas spectacle.

As Precigen leaders prepare for a key investor chat, all eyes are on the explosive launch of PAPZIMEOS and the company's ambitious path to profitability.